Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis: duration of therapy in invasive aspergillosis
- Author(s)
- Desoubeaux, G; Mikulska, M; Lemaignen, A; Gyan, E; Stemler, J; Vanbiervliet, Y; Maertens, J; Lortholary, O; Paccoud, O; Slavin, MA; Cornely, OA; Neofytos, D; Lanternier, F;
- Journal Title
- Clinical Microbiology and Infection
- Publication Type
- Online publication before print
- Keywords
- aspergillosis; clinical trial; curative therapy; duration; haematology; isavuconazole; voriconazole
- Department(s)
- Infectious Diseases
- Publisher's Version
- https://doi.org/10.1016/j.cmi.2026.01.030
- Open Access at Publisher's Site
https://doi.org/10.1016/j.cmi.2026.01.030- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-02-19 05:52:47
Last Modified: 2026-02-19 05:53:12